NCI/CMS Group Will Examine Coverage For Off-Label Cancer Drug Use

The collaboration between the National Cancer Institute and Centers for Medicare & Medicaid Services will work to formulate a policy that may be useful for commercial health insurance coverage of drugs, an NCI rep says.